Skip to content

Midurethral Synthetic Tape With Tension Control Mechanism Versus Midurethral Free Tape

Evaluation of the Effectiveness and Safety of the Midurethral Synthetic Tape With Tension Control Mechanism and Midurethral Tension Free Tape

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04101279
Enrollment
120
Registered
2019-09-24
Start date
2018-04-01
Completion date
2019-12-31
Last updated
2019-09-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Stress Incontinence

Keywords

stress urinary incontinence, midurethral tension free tape, patient reported outcome, bladder outlet obstruction, complications, tension control mechanism

Brief summary

This is a prospective, comparative randomized controled trial. The general purposes of this study is to compare the efficacy and safety of midurethral synthetic tape with tension control mechanism and conventional midurethral tension free tape as surgical treatment for female urinary stress incontinence.

Interventions

PROCEDUREsurgical management of stress urinary incontinence with midurethral tension free tape.

Standard protocol for the surgical treatment of stress urinary incontinence using a transobturator approach.

PROCEDUREsurgical management of stress urinary incontinence with synthetic tape with tension control mechanism.

Standard protocol for the surgical treatment of stress urinary incontinence using a transobturator approach. A absorbing gasket attached to the middle of the tape provides tension control.

Sponsors

Moscow State University of Medicine and Dentistry
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized controlled comparative study

Eligibility

Sex/Gender
FEMALE
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Women suffering from stress urinary incontinence, mixed urinary incontinence with prevalence stress urinary incontinence

Exclusion criteria

* Pregnancy * Women with neurogenic bladder dysfunction * Recurrent stress urinary incontinence * Woman with history of pelvic surgery * Mixed urinary incontinence with prevalence urgency urinary incontinence * Women who suffer from advanced POP (POP-Quantification system (POP-Q) stage more than 2) * Women with acute urinary tract infection * Women with bladder outlet obstruction * Women who are not able to give informed consent or participate with this randomized research study for any other reason

Design outcomes

Primary

MeasureTime frameDescription
Patient reported outcome measured as urogenital distress inventory (UDI-6) will be assessed before and after surgery at 12 weeks and 1 year.1 yearThe UDI measures the impact of urinary incontinence on activities, roles, and emotional states in women. This questionnaire presented six questions related to urinary disorders. The patient could answer Not at all, A little bit, Moderately or Greatly, to each of the questions, each answer is evaluated at 0, 1, 2 or 3 points, respectively, and then summed up. The final score means that the greater the sum of the indicators, the worse the patient's condition. This score reflects the condition of the patient before and after surgery at 12 weeks and 1 year.

Secondary

MeasureTime frameDescription
Bladder outlet obstruction measured during urodynamics pressure flow study1 yearWhen the urodynamic research indicators deviate (Qmax \< 12 ml/s and Postvoid residual volume (PVR) \> 100 ml, we establish a diagnosis bladder outlet obstruction.
Stress cough test measured before and after surgery.1 yearObjective cure rate will be not the leakage at physical examination cough test with full bladder (200-400ml)

Countries

Russia

Contacts

Primary ContactLyudmila Potapova
urodep@msmsu.ru+7(915)248-30-20
Backup ContactSergei Sukhikh
clinicaltrails@msmsu.ru+7(985)307-74-50

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026